{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:24:16Z","timestamp":1767849856069,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T00:00:00Z","timestamp":1487808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T00:00:00Z","timestamp":1487808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberculosis (TB) poses a serious public health problem in Angola. No surveillance data on drug resistance is available and nothing is known regarding the genetic diversity and population structure of circulating <jats:italic>Mycobacterium tuberculosis<\/jats:italic> strains. Here, we have genotyped and evaluated drug susceptibility of 89 <jats:italic>Mycobacterium tuberculosis<\/jats:italic> clinical isolates from Luanda. Thirty-three different spoligotype profiles corresponding to 24 different Shared International Types (SIT) and 9 orphan profiles were detected. SIT 20 (LAM1) was the most prevalent (n\u2009=\u200916, 18.2%) followed by SIT 42 (LAM9; n\u2009=\u200915, 17.1%). Overall, the <jats:italic>M. tuberculosis<\/jats:italic> population structure in this sample was dominated by LAM (64.8%) and T (33.0%) strains. Twenty-four-<jats:italic>loci<\/jats:italic> MIRU-VNTR analysis revealed that a total of 13 isolates were grouped in 5 distinct clusters. Drug susceptibility data showed that 22 (24.7%) of the 89 clinical isolates were resistant to one or more antibacillary drugs of which 4 (4.5%) were multidrug resistant. In conclusion, this study demonstrates a high predominance of LAM strains circulating in the Luanda setting and the presence of recent transmission events. The rate and the emergence dynamics of drug resistant TB found in this sample are significant and highlight the need of further studies specifically focused on MDR-TB transmission.<\/jats:p>","DOI":"10.1038\/srep42814","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T10:16:04Z","timestamp":1487844964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in Angola"],"prefix":"10.1038","volume":"7","author":[{"given":"Jo\u00e3o","family":"Perdig\u00e3o","sequence":"first","affiliation":[]},{"given":"Sofia","family":"Clemente","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Ramos","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Masakidi","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Couto","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Viveiros","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Portugal","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"BFsrep42814_CR1","unstructured":"World Health Organization. Global Tuberculosis Report 2015. (World Health Organization, Geneva, 2015)."},{"key":"BFsrep42814_CR2","unstructured":"Direc\u00e7\u00e3o Provincial de Sa\u00fade. Relat\u00f3rio Anual de 2013 - Prov\u00edncia de Luanda. (Direc\u00e7\u00e3o Provincial de Sa\u00fade, Governo Provincial de Luanda, Rep\u00fablica de Angola, Luanda, 2013)."},{"key":"BFsrep42814_CR3","unstructured":"World Health Organization. Global Tuberculosis Report 2014. (World Health Organization, Geneva, 2014)."},{"key":"BFsrep42814_CR4","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1056\/NEJM199406163302403","volume":"330","author":"D Alland","year":"1994","unstructured":"Alland, D. et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 330, 1710\u20131716 (1994).","journal-title":"N Engl J Med"},{"key":"BFsrep42814_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0140-6736(93)92698-S","volume":"342","author":"A Genewein","year":"1993","unstructured":"Genewein, A. et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 342, 841\u2013844 (1993).","journal-title":"Lancet"},{"key":"BFsrep42814_CR6","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1056\/NEJM199406163302402","volume":"330","author":"PM Small","year":"1994","unstructured":"Small, P. M. et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 330, 1703\u20131709 (1994).","journal-title":"N Engl J Med"},{"key":"BFsrep42814_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature02837","volume":"431","author":"MB Reed","year":"2004","unstructured":"Reed, M. B. et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84\u201387 (2004).","journal-title":"Nature"},{"key":"BFsrep42814_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1186\/1471-2164-15-991","volume":"15","author":"J Perdigao","year":"2014","unstructured":"Perdigao, J. et al. Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting. BMC Genomics 15, 991 (2014).","journal-title":"BMC Genomics"},{"key":"BFsrep42814_CR9","doi-asserted-by":"publisher","first-page":"e1000034","DOI":"10.1371\/journal.ppat.1000034","volume":"4","author":"M Caws","year":"2008","unstructured":"Caws, M. et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 4, e1000034 (2008).","journal-title":"PLoS Pathog"},{"key":"BFsrep42814_CR10","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1038\/ncomms5812","volume":"5","author":"F Coll","year":"2014","unstructured":"Coll, F. et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun 5, 4812 (2014).","journal-title":"Nat Commun"},{"key":"BFsrep42814_CR11","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/JCM.01392-06","volume":"44","author":"P Supply","year":"2006","unstructured":"Supply, P. et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44, 4498\u20134510 (2006).","journal-title":"J Clin Microbiol"},{"key":"BFsrep42814_CR12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/jcm.35.4.907-914.1997","volume":"35","author":"J Kamerbeek","year":"1997","unstructured":"Kamerbeek, J. et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35, 907\u2013914 (1997).","journal-title":"J Clin Microbiol"},{"key":"BFsrep42814_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1046\/j.1365-2958.2000.01905.x","volume":"36","author":"P Supply","year":"2000","unstructured":"Supply, P. et al. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 36, 762\u2013771 (2000).","journal-title":"Mol Microbiol"},{"key":"BFsrep42814_CR14","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1128\/jcm.28.12.2668-2673.1990","volume":"28","author":"D Thierry","year":"1990","unstructured":"Thierry, D. et al. Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis. J Clin Microbiol 28, 2668\u20132673 (1990).","journal-title":"J Clin Microbiol"},{"key":"BFsrep42814_CR15","doi-asserted-by":"publisher","first-page":"W326","DOI":"10.1093\/nar\/gkq351","volume":"38","author":"T Weniger","year":"2010","unstructured":"Weniger, T., Krawczyk, J., Supply, P., Niemann, S. & Harmsen, D. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res 38, W326\u2013331 (2010).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep42814_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.meegid.2012.02.004","volume":"12","author":"C Demay","year":"2012","unstructured":"Demay, C. et al. SITVITWEB\u2013a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol 12, 755\u2013766 (2012).","journal-title":"Infect Genet Evol"},{"key":"BFsrep42814_CR17","unstructured":"van Soolingen, D., de Haas, P. E. W. & Kremer, K. Restriction fragment length polymorphism (RFLP) typing of mycobacteria. Bilthoven, The Netherlands: National Intitute of Public Health and The Environment. 52 (2002)."},{"key":"BFsrep42814_CR18","unstructured":"Siddiqi, S. & R\u00fcsch-Gerdes, S. MGIT960 Procedure Manual for BACTECTM MGIT 960TM TB System (Also applicable for Manual MGIT). Mycobacteria growth indicator tube (MGIT) culture and drug susceptibility demonstration projects. (Foundation for innovative new diagnostics Ed., 2006)."},{"key":"BFsrep42814_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.meegid.2006.03.003","volume":"6","author":"I Vitol","year":"2006","unstructured":"Vitol, I., Driscoll, J., Kreiswirth, B., Kurepina, N. & Bennett, K. P. Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infect Genet Evol 6, 491\u2013504 (2006).","journal-title":"Infect Genet Evol"},{"key":"BFsrep42814_CR20","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/jcm.26.11.2465-2466.1988","volume":"26","author":"PR Hunter","year":"1988","unstructured":"Hunter, P. R. & Gaston, M. A. Numerical index of the discriminatory ability of typing systems: an application of Simpson\u2019s index of diversity. J Clin Microbiol 26, 2465\u20132466 (1988).","journal-title":"J Clin Microbiol"},{"key":"BFsrep42814_CR21","first-page":"DC05","volume":"8","author":"MR Torkaman","year":"2014","unstructured":"Torkaman, M. R. et al. Estimation of Recent Transmission of Mycobacterium Tuberculosis Strains among Iranian and Afghan Immigrants: A Cluster-Based Study. J Clin Diagn Res 8, DC05\u201308 (2014).","journal-title":"J Clin Diagn Res"},{"key":"BFsrep42814_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/qjmed\/hcu139","volume":"108","author":"ML Munang","year":"2015","unstructured":"Munang, M. L., Kariuki, M. & Dedicoat, M. Isoniazid-resistant tuberculosis in Birmingham, United Kingdom, 1999\u20132010. QJM 108, 19\u201325 (2015).","journal-title":"QJM"},{"key":"BFsrep42814_CR23","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1371\/journal.pmed.0030384","volume":"3","author":"H Cox","year":"2006","unstructured":"Cox, H. et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med 3, e384 (2006).","journal-title":"PLoS Med"},{"key":"BFsrep42814_CR24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1086\/522987","volume":"45","author":"M Pillay","year":"2007","unstructured":"Pillay, M. & Sturm, A. W. Evolution of the extensively drug-resistant F15\/LAM4\/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis 45, 1409\u20131414 (2007).","journal-title":"Clin Infect Dis"},{"key":"BFsrep42814_CR25","doi-asserted-by":"publisher","first-page":"e1001880","DOI":"10.1371\/journal.pmed.1001880","volume":"12","author":"KA Cohen","year":"2015","unstructured":"Cohen, K. A. et al. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. PLoS Med 12, e1001880 (2015).","journal-title":"PLoS Med"},{"key":"BFsrep42814_CR26","first-page":"938178","volume":"2010","author":"C Mulenga","year":"2010","unstructured":"Mulenga, C. et al. Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia. Tuberc Res Treat 2010, 938178 (2010).","journal-title":"Tuberc Res Treat"},{"key":"BFsrep42814_CR27","doi-asserted-by":"publisher","first-page":"e10799","DOI":"10.1371\/journal.pone.0010799","volume":"5","author":"GX He","year":"2010","unstructured":"He, G. X. et al. Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment. PLoS ONE 5, e10799 (2010).","journal-title":"PLoS ONE"},{"key":"BFsrep42814_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","volume":"149","author":"W Lew","year":"2008","unstructured":"Lew, W., Pai, M., Oxlade, O., Martin, D. & Menzies, D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 149, 123\u2013134 (2008).","journal-title":"Ann Intern Med"},{"key":"BFsrep42814_CR29","doi-asserted-by":"publisher","first-page":"e0127536","DOI":"10.1371\/journal.pone.0127536","volume":"10","author":"P Rabna","year":"2015","unstructured":"Rabna, P. et al. Direct Detection by the Xpert MTB\/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa. PLoS ONE 10, e0127536 (2015).","journal-title":"PLoS ONE"},{"key":"BFsrep42814_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ympev.2016.03.020","volume":"99","author":"I Mokrousov","year":"2016","unstructured":"Mokrousov, I. et al. Latin-American-Mediterranean lineage of Mycobacterium tuberculosis: Human traces across pathogen\u2019s phylogeography. Mol Phylogenet Evol 99, 133\u2013143 (2016).","journal-title":"Mol Phylogenet Evol"},{"key":"BFsrep42814_CR31","unstructured":"United Nations High Commissioner for Refugees. 2004 UNHCR Statistical Yearbook. (United Nations High Commissioner for Refugees, Geneva, 2006)."},{"key":"BFsrep42814_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.meegid.2008.05.003","volume":"9","author":"I Bartolo","year":"2009","unstructured":"Bartolo, I. et al. Highly divergent subtypes and new recombinant forms prevail in the HIV\/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic. Infect Genet Evol 9, 672\u2013682 (2009).","journal-title":"Infect Genet Evol"},{"key":"BFsrep42814_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2180-8-103","volume":"8","author":"S Homolka","year":"2008","unstructured":"Homolka, S. et al. High genetic diversity among Mycobacterium tuberculosis complex strains from Sierra Leone. BMC Microbiol 8, 103 (2008).","journal-title":"BMC Microbiol"},{"key":"BFsrep42814_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1471-2334-10-177","volume":"10","author":"C Mulenga","year":"2010","unstructured":"Mulenga, C. et al. Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia. BMC Infect Dis 10, 177 (2010).","journal-title":"BMC Infect Dis"},{"key":"BFsrep42814_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12916-015-0341-4","volume":"13","author":"GH Huynh","year":"2015","unstructured":"Huynh, G. H. et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med 13, 88 (2015).","journal-title":"BMC Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42814","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:18:23Z","timestamp":1671844703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,27]]}},"alternative-id":["BFsrep42814"],"URL":"https:\/\/doi.org\/10.1038\/srep42814","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]},"assertion":[{"value":"12 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42814"}}